Chronic Kidney Disease (CKD)/ ACR
What is Chronic Kidney Disease (CKD)?
CKD means reduced kidney function or kidney damage that lasts more than 3 months.
- eGFR < 60 on at least 2 tests, 3 months apart
- Or normal eGFR with evidence of kidney damage (e.g. raised urine ACR, persistent blood in urine, abnormal imaging) for > 3 months
Common Causes
- Diabetes mellitus
- Hypertension
- Glomerulonephritis
- Polycystic kidney disease
- Obstructive uropathy (e.g. BPH, stones)
- Recurrent urinary tract infections
- Medications (e.g. NSAIDs, lithium)
Stepwise Primary Care Approach
Step 1: Confirm CKD
- Repeat eGFR in 3 months if new finding and patient well
- Check urine ACR and urine dip (blood/protein)
- Rule out AKI: ask about vomiting/diarrhoea, infection, new medications, reduced urine
Step 2: Classify CKD Stage
- G1: eGFR ≥ 90 with evidence of damage
- G2: eGFR 60-89 with evidence of damage
- G3a: eGFR 45-59
- G3b: eGFR 30-44
- G4: eGFR 15-29
- G5: eGFR < 15
Albuminuria: A1 (< 3 mg/mmol), A2 (3-30), A3 (> 30)
Step 3: Initial Investigations
- Urine ACR
- Urine dip for blood and protein
- U&Es and eGFR (baseline)
- FBC (anaemia)
- HbA1c (diabetes)
- Calcium (and phosphate if CKD stage 3b or worse)
- Blood pressure measurement
- Renal ultrasound if:
- eGFR < 45
- Persistent haematuria
- Suspected obstruction
- Suspected polycystic kidney disease
Step 4: Management in Primary Care
- Blood pressure target:
- < 140/90 if ACR < 30
- < 130/80 if ACR ≥ 30
- ACE inhibitor or ARB: try if ACR ≥ 3 (especially diabetes or hypertension)
- Diabetes: aim for individualised HbA1c target
- Statin: try atorvastatin 20 mg nocte for CKD (primary prevention is usually recommended)
- Avoid harm: avoid NSAIDs and review nephrotoxic medicines
- Vaccines: try annual flu vaccine, and pneumococcal vaccine as appropriate
- Diet advice: reduce salt intake, avoid high salt processed foods
Step 5: Monitoring (Simple and Practical)
- G1-G2: monitor based on ACR and risk factors
- G3a with A1: repeat U&Es and ACR yearly
- G3a with A2/A3: repeat every 6 months
- G3b: repeat every 3-6 months
- G4: repeat every 3 months (often shared care with nephrology)
- Always recheck U&Es 1-2 weeks after starting or increasing ACE inhibitor or ARB
Step 6: When to Refer to Nephrology
- eGFR < 30 (G4-G5)
- ACR ≥ 70 mg/mmol unless clearly due to diabetes and already optimised
- Persistent haematuria with proteinuria
- Rapid decline in kidney function:
- eGFR drop ≥ 5 in 1 year
- or ≥ 10 within 5 years
- Resistant hypertension despite 4 drugs
- Suspected systemic or inflammatory renal disease
- Structural abnormality on imaging (e.g. hydronephrosis, polycystic disease)
What is ACR?
Albumin:creatinine ratio (ACR) detects and quantifies protein (albumin) loss in urine. It is a key test in diagnosing and monitoring CKD, especially in people with diabetes or hypertension.
Reference Ranges (Spot Urine Sample)
- < 3 mg/mmol: no action needed
- 3 - 70 mg/mmol: repeat ACR within 3 months
- > 70 mg/mmol: indicates significant proteinuria - no repeat needed, proceed with CKD workup
Stepwise Clinical Approach
Step 1: First Sample
Request early morning urine ACR sample. Avoid samples during menstruation or UTI.
Step 2: If ACR ≥ 3 mg/mmol
- Repeat 2 additional early morning samples within 3 months
- Diagnosis of proteinuria confirmed if 2 out of 3 ACR results ≥ 3 mg/mmol
- Use PCR (protein:creatinine ratio) if ACR > 70 mg/mmol or to monitor treatment
Step 3: Rule Out Transient Causes
- Exclude UTI (send MSU if dipstick positive)
- Post-exercise, fever, or upright posture may temporarily raise ACR
Step 4: Check for CKD
- Repeat eGFR and ACR 3 months apart
- CKD is diagnosed if ACR ≥ 3 mg/mmol or eGFR < 60 for > 3 months
- Classify CKD based on ACR and eGFR together
Step 5: Additional Investigations
- BP, HbA1c, lipid profile, BMI, and dipstick for haematuria
- Renal ultrasound if: structural abnormalities suspected, family history of polycystic kidney disease, or aged > 20
Step 6: When to Refer to Nephrology
- ACR persistently > 70 mg/mmol (even with normal eGFR)
- ACR 30 - 70 mg/mmol with haematuria or reduced eGFR
- Progressive decline in eGFR or uncontrolled hypertension